A patient with non-ST elevation myocardial infarction (NSTEMI) continues to experience chest pain despite a continuous intravenous infusion of nitroglycerin. Which is the most appropriate nursing intervention to manage the patient's persistent chest pain and optimize myocardial perfusion?

B) Administer morphine sulfate to provide additional pain relief and decrease myocardial oxygen demand.

A) Increase the nitroglycerin infusion rate to achieve better pain control.

B) Administer morphine sulfate to provide additional pain relief and decrease myocardial oxygen demand.

C) Initiate a high-flow oxygen therapy to increase oxygen delivery to the myocardium.

D) Prepare the patient for immediate coronary angiography to assess the need for revascularization.

A patient with worsening ischemia and signs of cardiogenic shock is being prepared for coronary angiography. Which nursing intervention is most important to implement prior to the procedure to ensure patient safety?

C) Monitor renal function to minimize the risk of contrast-induced nephropathy.

A) Administer a diuretic to reduce cardiac workload.

B) Ensure the patient is NPO (nothing by mouth) to prevent aspiration.

C) Monitor renal function to minimize the risk of contrast-induced nephropathy.

D) Provide sedatives to alleviate anxiety about the procedure.

A patient with worsening chest pain, hypotension, and hypoxemia despite medical therapy is being prepared for emergent coronary angiography. The nurse should prioritize which of the following actions to best prepare the patient for the procedure?

B) Monitoring fluid intake and output closely to assess renal function

A) Administering a full meal to ensure the patient has enough energy for the procedure

B) Monitoring fluid intake and output closely to assess renal function

C) Encouraging the patient to ambulate to prevent deep vein thrombosis

D) Discontinuing oxygen therapy to prepare for transport

A patient has just undergone percutaneous coronary intervention (PCI) for critical stenosis in the left anterior descending artery. During the post-procedure period in the intensive care unit, which nursing intervention is a priority to prevent potential complications?

B) Monitor urine output and serum creatinine levels closely.

A) Encourage early ambulation to prevent deep vein thrombosis.

B) Monitor urine output and serum creatinine levels closely.

C) Administer a high-sodium diet to support fluid balance.

D) Restrict fluid intake to prevent pulmonary edema.

A patient in the ICU post-percutaneous coronary intervention (PCI) exhibits stable vital signs and improved respiratory status. However, the nurse notices a sudden increase in the patient's heart rate to 120 beats per minute and a decrease in blood pressure to 90/60 mmHg. What is the nurse's priority action?

B) Reassess the patient's cardiac rhythm and check for arrhythmias.

A) Increase the patient's fluid intake.

B) Reassess the patient's cardiac rhythm and check for arrhythmias.

C) Administer a dose of nitroglycerin.

D) Prepare to administer a diuretic.

A patient in the intensive care unit post-PCI develops atrial fibrillation and mild acute kidney injury. The healthcare team has initiated IV diltiazem for rate control. What is the nurse's priority intervention to address the patient's current issues and prevent further complications?

D) Evaluate the patient's fluid status and urine output hourly.

A) Monitor the patient's heart rate and rhythm every 15 minutes for the first hour.

B) Increase the infusion rate of isotonic saline to enhance renal perfusion.

C) Initiate anticoagulation therapy immediately to prevent thromboembolic events.

D) Evaluate the patient's fluid status and urine output hourly.

A patient in the intensive care unit develops atrial fibrillation with a fluctuating heart rate after undergoing PCI. Additionally, the patient shows signs of acute kidney injury with reduced urine output. What is the most critical nursing intervention to prioritize at this time?

C) Initiate intravenous hydration to support renal perfusion.

A) Administer intravenous diltiazem to maintain heart rate control.

B) Start anticoagulation therapy to prevent thromboembolic events.

C) Initiate intravenous hydration to support renal perfusion.

D) Monitor oxygen saturation continuously to detect respiratory complications.

A patient with a history of recent PCI and atrial fibrillation is experiencing signs of fluid overload following aggressive IV hydration. After initiating low-dose intravenous furosemide, which nursing intervention is the most appropriate to evaluate the effectiveness of the treatment?

B) Assess the patient's lung sounds for improvement in crackles.

A) Monitor the patient's blood pressure for any changes.

B) Assess the patient's lung sounds for improvement in crackles.

C) Check the patient's heart rate for further stabilization.

D) Evaluate the patient's jugular venous distension.

A patient with a history of atrial fibrillation and recent PCI is being managed for volume overload. The healthcare team has reduced intravenous fluids and initiated low-dose intravenous furosemide. Which nursing intervention is most appropriate to assess the effectiveness of these interventions in managing the patient's fluid status?

A) Monitor the patient's urine output closely

B) Increase the frequency of blood pressure checks

C) Assess the patient's heart rate every hour

D) Evaluate the patient's pain level regularly

angina - Nursing Case Study

Pathophysiology

• Primary mechanism: Angina primarily results from an imbalance between myocardial oxygen supply and demand, often due to coronary artery narrowing from atherosclerosis, which reduces blood flow to the heart muscle, leading to ischemia and chest pain.

• Secondary mechanism: Endothelial dysfunction contributes to angina by impairing the ability of coronary arteries to dilate properly in response to increased oxygen needs, further limiting blood supply during physical exertion or stress.

• Key complication: Prolonged ischemia can lead to myocardial infarction, where sustained lack of blood flow causes irreversible damage to heart tissue, highlighting the importance of timely recognition and management of angina symptoms.

Patient Profile

Demographics:

58-year-old male, office manager

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metoprolol, Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain lasting more than 15 minutes

• Key symptoms: Tightness in the chest, shortness of breath, nausea, mild dizziness

• Vital signs: Blood pressure 160/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 93% on room air

Section 1

In the initial assessment, further evaluation of the patient's condition reveals additional concerning findings. Upon auscultation, a new S4 heart sound is detected, indicating possible left ventricular hypertrophy or increased stiffness, which is often associated with underlying hypertensive heart disease. The patient shows signs of mild diaphoresis and pallor, suggesting increased sympathetic nervous system activity in response to myocardial ischemia. An electrocardiogram (ECG) is performed, showing ST-segment depression in the anterior leads, consistent with subendocardial ischemia. These findings raise the suspicion of unstable angina, necessitating prompt intervention to prevent progression to myocardial infarction.

The healthcare team decides to order a series of laboratory tests to further assess the patient's cardiovascular status. Cardiac biomarkers, including troponin levels, are elevated, indicating myocardial cell injury. This finding, combined with the patient's symptoms and ECG changes, confirms the diagnosis of non-ST elevation myocardial infarction (NSTEMI). The patient's renal function is also evaluated, revealing a slightly elevated creatinine level of 1.4 mg/dL, which is crucial for medication management, especially regarding anticoagulant therapy. These results emphasize the need for a coordinated approach to manage potential complications and optimize myocardial perfusion, such as initiating dual antiplatelet therapy and considering coronary angiography for potential revascularization.

The patient is started on a continuous intravenous infusion of nitroglycerin to alleviate chest pain and reduce cardiac workload by decreasing preload and afterload. Despite these interventions, the patient's chest pain persists, necessitating further clinical reasoning to adjust the treatment plan. The healthcare team considers additional strategies, such as titration of beta-blockers to achieve better heart rate control and the potential need for an early invasive strategy due to the high-risk features observed. The patient’s response to these interventions will guide the next steps in management, focusing on preventing further myocardial damage and stabilizing his condition.

Section 2

As the healthcare team continues to monitor the patient's condition, they observe a change in his status that warrants immediate attention. Despite the administration of nitroglycerin and the initiation of beta-blocker therapy, the patient's chest pain escalates from a 5 to an 8 on a 10-point scale, accompanied by increasing shortness of breath. Vital signs reveal a blood pressure that has dropped to 95/60 mmHg, a heart rate of 105 beats per minute, and a respiratory rate of 24 breaths per minute, indicating a potential hemodynamic compromise. The patient's oxygen saturation has decreased to 90% on room air, necessitating supplemental oxygen to maintain adequate saturation levels.

In light of these changes, the healthcare team performs a repeat ECG, which shows persistent ST-segment depression with new T-wave inversions in the anterior and lateral leads. These findings suggest worsening ischemia, possibly due to inadequate perfusion despite ongoing medical therapy. Concurrently, a repeat set of cardiac biomarkers reveals a further increase in troponin levels, indicating continued myocardial cell damage. The team recognizes the urgency of the situation and the potential development of cardiogenic shock, given the combination of hypotension, tachycardia, and hypoxia.

The team discusses the need for an early invasive strategy, considering the patient's deteriorating condition and high-risk features. A decision is made to transfer the patient to the cardiac catheterization lab for coronary angiography to identify any critical lesions that require immediate revascularization. The primary goal is to restore blood flow and prevent additional myocardial injury. This step is crucial not only for stabilizing the patient's current status but also for reducing the risk of future complications. The patient is prepared for the procedure, with careful attention to his renal function to minimize contrast-induced nephropathy, highlighting the importance of balancing aggressive treatment with the patient's overall clinical picture.

Section 3

As the patient is transferred to the cardiac catheterization lab, further assessment reveals additional concerns. Despite the administration of supplemental oxygen, the patient remains tachypneic with a respiratory rate of 26 breaths per minute, and his oxygen saturation hovers around 92% with nasal cannula oxygen at 4 liters per minute. Auscultation of the lungs reveals fine crackles at the bases, suggesting the onset of pulmonary congestion, likely secondary to left ventricular dysfunction. This finding is corroborated by a chest X-ray performed en route, which shows mild pulmonary edema. The patient’s jugular venous pressure is elevated, indicating increased central venous pressure and potential fluid overload.

In the catheterization lab, coronary angiography uncovers a significant 95% stenosis in the proximal left anterior descending artery, with moderate stenosis in the right coronary artery. These critical findings confirm the need for immediate percutaneous coronary intervention (PCI) to restore adequate perfusion. The interventional cardiologist proceeds with balloon angioplasty followed by the placement of a drug-eluting stent in the affected artery. Meanwhile, the patient's hemodynamic status is closely monitored, and an intra-aortic balloon pump (IABP) is prepared as a contingency to support cardiac output should there be further compromise.

Post-procedure, the patient is transferred to the intensive care unit for close observation. Initial post-PCI reports are promising, as the patient's chest pain resolves, and his blood pressure stabilizes at 110/70 mmHg with a heart rate of 88 beats per minute. However, the team remains vigilant for potential complications such as reperfusion arrhythmias or acute kidney injury from contrast use. Renal function is monitored closely, with creatinine levels remaining stable at 1.2 mg/dL. The patient’s respiratory status improves, with oxygen saturation rising to 95% on room air. This stabilization marks a positive turn in his immediate postoperative care, but the healthcare team remains alert to the possibility of further cardiac or systemic complications as the patient continues his recovery.

Section 4

As the patient settles into the intensive care unit, the healthcare team remains vigilant for any changes in his condition. Within the first few hours post-PCI, the patient begins to exhibit subtle shifts in his clinical status. Although his chest pain has resolved, the patient's heart rate becomes irregular, suggesting the onset of atrial fibrillation, a common reperfusion arrhythmia. His heart rate fluctuates between 110 and 130 beats per minute, and an ECG confirms the irregular rhythm. This development prompts the medical team to initiate a rate-control strategy with intravenous diltiazem, which successfully reduces the heart rate to a more manageable range of 80-90 beats per minute.

While the arrhythmia is being managed, the patient reports new onset of mild flank pain and discomfort. Concerned about the potential nephrotoxic effects of the contrast media used during the PCI, the team orders a repeat renal panel. The latest laboratory results reveal a rise in serum creatinine to 1.6 mg/dL, indicating a mild acute kidney injury. The patient’s urine output decreases to 25 mL/hour, further corroborating the renal impairment. The team responds swiftly with intravenous hydration using isotonic saline to support renal perfusion and closely monitors electrolyte levels to prevent any imbalances.

The patient's respiratory status remains stable, with oxygen saturation consistently around 95% on room air. However, the combination of atrial fibrillation and acute kidney injury prompts a comprehensive review of his medication regimen to mitigate further complications. The team discusses the potential need for anticoagulation, balancing the risk of thromboembolic events against the potential for bleeding, especially in the context of recent PCI. As the patient progresses through these challenges, the healthcare team remains vigilant, employing clinical reasoning to guide ongoing management and prevent further deterioration in his condition.

Section 5

Hours into the management of the patient's condition, the healthcare team identifies another shift in his clinical status that requires immediate attention. Despite successful rate control of the atrial fibrillation, the patient begins to exhibit signs of volume overload, likely a consequence of aggressive intravenous hydration. The physical assessment reveals mild jugular venous distension and crackles at the lung bases, raising concerns about potential pulmonary congestion. His blood pressure has risen to 160/95 mmHg, and his heart rate, though controlled, remains at 85 beats per minute. Additionally, the patient reports mild shortness of breath, and his oxygen saturation has decreased slightly to 92% on room air.

In response to these findings, the team decides to adjust the fluid management strategy. They reduce the rate of intravenous fluids and initiate low-dose intravenous furosemide to mitigate fluid overload while closely monitoring the patient's hemodynamic status and lung sounds. A repeat chest X-ray is ordered to assess the extent of pulmonary congestion, and the results confirm mild pulmonary edema. The team also re-evaluates the patient's renal function, noting a serum creatinine level holding steady at 1.6 mg/dL, indicating no further deterioration of kidney function.

The healthcare team considers the delicate balance required in managing the patient's fluid status, atrial fibrillation, and renal function. They emphasize the importance of regular monitoring and reassessment, recognizing the interconnected nature of cardiovascular, renal, and respiratory systems in this complex case. As the patient stabilizes with the revised interventions, the team prepares for potential future challenges, particularly the ongoing risk of thromboembolic events given the patient's atrial fibrillation and recent PCI. This prompts further discussion regarding anticoagulation therapy, weighing the benefits against potential complications in this delicate post-procedural phase.